8 terminated. 8 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 8 | Terminated 8 |
Follow Interleukin-7: new trials by email Literature Review of Interleukin-7 trials Research Report on Interleukin-7
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort) Interleukin-7, PLACEBO - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 4 | 2021-03-01 | 2024-04-12 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O ) CYT107, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 10 | 2020-12-20 | 2024-04-11 |
| Recombinant Interleukin-7 (CYT107) to Treat Patients With Refractory Nontuberculous Mycobacterial Lung Disease Recombinant human interleukin-7 - Mycobacterium Infections, Nontuberculous | Phase 2 | Terminated | Revimmune | 8 | 2020-11-30 | 2024-04-11 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection ( ILIAD-7-US-I ) CYT107, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 26 | 2020-09-15 | 2022-04-08 |
| InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection FR BL Cohort Interleukin-7, Placebo - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 34 | 2020-06-08 | 2022-04-08 |
| InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection UK Cohort Interleukin-7, Placebos - COVID-19, Lymphocytopenia | Phase 2 | Terminated | Revimmune | 35 | 2020-05-14 | 2022-04-07 |
| Immune Reconstitution of Immunosuppressed Sepsis Patients Interleukin-7, Placebo - Severe Sepsis With Septic Shock | Phase 2 | Terminated | University Hospital, Limoges | 16 | 2016-01-14 | 2017-11-29 |
| Study on Interleukin-7 (CYT107) in HIV Patients Interleukin-7 - HIV | Phase 2 | Terminated | Cytheris SA | 23 | 2010-01-01 | 2013-08-01 |
COVID-19 (5) · Lymphopenia (5) · Mycobacterium Infections, Nontuberculous (1) · Virus Diseases (1)
Revimmune (6) · Cytheris SA (1) · University Hospital, Limoges (1)
United States (4) · France (2) · Brazil (1) · Canada (1) · United Kingdom (1)
Manu Shankar-Hari, MD PhD (1) · Marcel van den Brink, MD, PhD (1) · Michael M. Lederman,, Pr (1) · Richard Hotchkiss, MD PhD (1) · Steve Pastores, MD (1)
PMID 39903535, PMID 29515037, PMID 32031570, PMID 32171076, PMID 23053510, PMID 18946659, PMID 26908786, PMID 40351870